Hat Yai Medical Education Center Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2016
NCT02725242
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Hat Yai Medical Education Center

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 3)

Communicable Diseases (Phase 3)

Infections (Phase 3)

Pneumonia (Phase 3)

Pneumonia, Ventilator-Associated (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 5